|
Feb 27
|
Ventripoint Diagnostics Announces U.S. FDA 510(k) Clearance for VMS+(TM) 4.0 Automated Radiological Image Processing Software/System
|
|
Mar 28
|
Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call
|
|
Dec 5
|
Ollie Hinkle Heart Foundation will Introduce Ventripoint's AI-Heart-Imaging Diagnostic Technology to America's Hospitals
|
|
Dec 1
|
VentriPoint Diagnostics Third Quarter 2023 Earnings: CA$0.007 loss per share (vs CA$0.009 loss in 3Q 2022)
|
|
Jul 18
|
Ventripoint's VMS+ Purchased by Medical Center - University of Freiburg
|
|
Apr 25
|
Ventripoint Announces Sponsorship of the 56th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
|